Morphic

$34.88
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.79 (+2.32%) Today
$0.00 (0.00%) As of 11:00 PM UTC after-hours

Why Robinhood?

You can buy or sell Morphic and other stocks, options, and ETFs commission-free!

About MORF

Morphic Holding, Inc. operates as a biopharmaceutical company, which engages in the research and development of oral small-molecule integrin therapeutics. It operates a Morphic integrin technology platform, MInT platform, to create a broad pipeline of programs across a variety of therapeutic areas. The company was founded by Timothy A. Springer in August 2014 and is headquartered in Waltham, MA. The listed name for MORF is Morphic Holding, Inc. Common Stock.

CEO
Praveen P. Tipirneni
Employees
76
Headquarters
Waltham, Massachusetts
Founded
2014
Market Cap
1.15B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
87.84K
High Today
$35.39
Low Today
$33.63
Open Price
$33.67
Volume
35.31K
52 Week High
$41.00
52 Week Low
$9.90

MORF Earnings

-$4.73
-$3.03
-$1.34
$0.36
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Available Mar 1, Pre-Market

You May Also Like

ACND=
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure